Medical Device 'Unannounced Inspections' Aim to Ensure Compliance and Product Safety, Highlighted at Optics Valley Seminar

Recently, at the Optics Valley Qingtong Hui Seminar on Compliance in Medical Device Product Design and Development, held at the Optics Valley Entrepreneurship Coffee shop in the Biopharmaceutical Park, experts from Zhizhong Technology, a professional institution based in Optics Valley, engaged in professional exchanges with participating companies and attendees on the theme of “Enhancing Compliance Awareness and Capabilities in Design and Development for Medical Device Companies.”

Experts at the conference introduced that unannounced inspections are surprise supervisory inspections conducted by food and drug regulatory authorities against administrative counterparts without prior notice. Based on the "Measures for Unannounced Inspections of Drugs and Medical Devices" implemented in 2015, the purpose is to standardize the design and development of products by medical device companies, identify issues, manage risks, deter illegal activities, and ensure consumer safety.

Chen Xi, Regulatory Director at Zhizhong Technology, provided an interpretation of the issues exposed during China’s unannounced inspections of medical device manufacturers last year. She revealed that Hubei Province ranked 17th among all provinces, municipalities, and autonomous regions in China, with three companies cited for non-conformities. The most frequently identified non-conformity involved irregular quality management records in the production process, such as unsigned documents, missing dates, and illegible or heavily altered handwriting—issues unrelated to product technology.

During the subsequent seminar session, technical experts including Xu Xinggang and Shi Guoqi engaged in discussions with representatives from over 40 companies—totaling more than 100 attendees—on professional topics such as the standardization of design and development for full-line medical devices, control of development processes, and key operational points at each stage.

“Optics Valley Qingtong Hui,” a startup initiative co-hosted by the Donghu High-Tech Development Zone Administrative Committee of Wuhan and the Wuhan Municipal Science and Technology Bureau, has established an entrepreneurial service platform that facilitates matchmaking between entrepreneurs and venture capital, enables dialogue with startup mentors, and promotes the sharing of innovation and entrepreneurship experiences. To date, the program has featured over 200 roadshow projects and promoted nearly 600 projects, attracting participation from more than 200 investment institutions and drawing over 30,000 attendees. According to incomplete statistics, more than 70 projects have secured cumulative financing of nearly RMB 2 billion, establishing “Optics Valley Qingtong Hui” as a well-known startup brand in China.

Wuhan Optics Valley Biopharmaceutical Technology Business Incubator is the first specialized incubator focused on the biopharmaceutical and health industries, established by the Wuhan National Bio-industry Base. Leveraging the advantageous resources of Bio-city, the Optics Valley Biopharmaceutical Incubator has developed robust infrastructure and a highly efficient service team. Since its establishment in 2011, the incubator has successively received accreditation as a technology business incubator from the East Lake High-Tech Development Zone, Wuhan City, and Hubei Province. In March 2016, it was officially recognized as a National-level Technology Business Incubator by the Ministry of Science and Technology. By building specialized platforms and technical teams, the Biopharmaceutical Incubator provides integrated and synergistic professional incubation services to resident enterprises.